These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25982351)

  • 1. Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population.
    Young RK; Dale B; Russell SD; Zachary AA; Tedford RJ
    Clin Transplant; 2015 Aug; 29(8):685-8. PubMed ID: 25982351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-vimentin antibodies in transplant and disease.
    Divanyan T; Acosta E; Patel D; Constantino D; Lopez-Soler RI
    Hum Immunol; 2019 Aug; 80(8):602-607. PubMed ID: 30926354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of anti-vimentin antibodies in allograft rejection.
    Rose ML
    Hum Immunol; 2013 Nov; 74(11):1459-62. PubMed ID: 23777935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed graft function is not associated with an increased incidence of renal allograft rejection.
    Hirt-Minkowski P; Amico P; Hönger G; Praehauser C; Steiger J; Koller MT; Gürke L; Mayr M; Schaub S
    Clin Transplant; 2012; 26(6):E624-33. PubMed ID: 23106785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.
    Jurcevic S; Ainsworth ME; Pomerance A; Smith JD; Robinson DR; Dunn MJ; Yacoub MH; Rose ML
    Transplantation; 2001 Apr; 71(7):886-92. PubMed ID: 11349721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of mean first-year heart rate on outcomes after heart transplantation: does it make a difference?
    Shah AB; Patel JK; Rafiei M; Morrissey RP; Kittleson MM; Kobashigawa JA
    Clin Transplant; 2013; 27(5):659-65. PubMed ID: 23924048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients.
    Thibodeau JT; Mishkin JD; Patel PC; Kaiser PA; Ayers CR; Mammen PP; Markham DW; Ring WS; Peltz M; Drazner MH
    Clin Transplant; 2012; 26(6):953-9. PubMed ID: 22775970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The policy of placing older donors into older recipients: is it worth the risk?
    Tehrani YS; Yu Z; Luu M; Liou F; Rafiei M; Hamilton M; Kobashigawa JA
    Clin Transplant; 2014 Jul; 28(7):802-7. PubMed ID: 24801014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
    Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival.
    Irving C; Carter V; Parry G; Hasan A; Kirk R
    Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late outcome after paediatric heart transplantation in Finland.
    Raissadati A; Pihkala J; Jahnukainen T; Jokinen E; Jalanko H; Sairanen H
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):18-25. PubMed ID: 27034098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S; Yang JK; Burke EM; Chen JM; Addonizio LJ; Mital SR; Itescu S; Hsu DT; Lamour JM
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection.
    Alvarez-Márquez A; Aguilera I; Blanco RM; Pascual D; Encarnación-Carrizosa M; Alvarez-López MR; Wichmann I; Núñez-Roldán A
    Hum Immunol; 2008 Mar; 69(3):143-8. PubMed ID: 18396205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart transplantation in females: the experience in Puerto Rico.
    Banchs HL; González V; González Cancel I; Quintana C; Calderón R; Altieri PI
    Bol Asoc Med P R; 2005; 97(4):248-56. PubMed ID: 16599066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elderly donor liver grafts are not associated with a higher incidence of biliary complications after liver transplantation: results of a national multicenter study.
    Westerkamp AC; Korkmaz KS; Bottema JT; Ringers J; Polak WG; van den Berg A; van Hoek B; Metselaar HJ; Porte RJ
    Clin Transplant; 2015 Jul; 29(7):636-43. PubMed ID: 25997000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.
    Auerbach SR; Kukreja M; Gilbert D; Bastardi H; Feingold B; Knecht K; Kaufman BD; Brown RN; Miyamoto SD
    J Heart Lung Transplant; 2015 Aug; 34(8):1066-72. PubMed ID: 25980572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.
    Lick SD; Beckles DL; Piovesana G; Vaidya S; Indrikovs A; Barbagelata NA; Valentine V
    Ann Thorac Surg; 2011 Oct; 92(4):1428-34. PubMed ID: 21855854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of pre- and post-transplant HLA antibodies, donor-specific, and nondonor-specific HLA antibodies detected by ELISA in renal transplantation.
    Lee PC; Chen YL; Wang WM; Tu WC; Chen HY
    Clin Transpl; 2013; ():385-91. PubMed ID: 25095533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.